Highlights from the I international symposium of thrombosis and anticoagulation in internal medicine, October 23-25, 2008, Sao Paulo, Brazil
Carregando...
Fontes externas
Fontes externas
Data
Orientador
Coorientador
Pós-graduação
Curso de graduação
Título da Revista
ISSN da Revista
Título de Volume
Editor
Springer Nature
Tipo
Artigo
Direito de acesso
Acesso restrito
Fontes externas
Fontes externas
Resumo
The importance of thrombosis and anticoagulation in clinical practice is rooted firmly in several fundamental constructs that can be applied both broadly and globally. Awareness and the appropriate use of anticoagulant therapy remain the keys to prevention and treatment. However, to assure maximal efficacy and safety, the clinician must, according to the available evidence, choose the right drug, at the right dose, for the right patient, under the right indication, and for the right duration of time. The first International Symposium of Thrombosis and Anticoagulation in Internal Medicine was a scientific program developed by clinicians for clinicians. The primary objective of the meeting was to educate, motivate and inspire internists, cardiologists and hematologists by convening national and international visionaries, thought-leaders and dedicated clinician-scientists in Sao Paulo, Brazil. This article is a focused summary of the symposium proceedings. © Springer Science+Business Media, LLC 2009.
Descrição
Palavras-chave
Anticoagulation Internal medicine Thrombosis acetylsalicylic acid anticoagulant agent antithrombin antithrombocytic agent antivitamin K apixaban azd 0837 betrixaban blood clotting factor 10a inhibitor clopidogrel dabigatran dalteparin du 176b enoxaparin fibrinogen receptor antagonist fondaparinux heparin hirulog low molecular weight heparin nadroparin placebo prasugrel purinergic receptor blocking agent reviparin rivaroxaban streptokinase thrombin inhibitor tm 150 unclassified drug unindexed drug warfarin ym 150 acute coronary syndrome angina pectoris anticoagulant therapy anticoagulation atherogenesis bleeding Brazil cerebrovascular accident clinical education clinical trial deep vein thrombosis drug mechanism drug metabolism embolism endothelial dysfunction fibrin clot heart atrium fibrillation heart infarction hemostasis heparin induced thrombocytopenia human internal medicine international normalized ratio low drug dose malignant neoplastic disease medical society orthopedic surgery oxidative stress pharmacogenomics practice guideline priority journal prosthetic valve thrombosis recommended drug dose risk assessment risk benefit analysis risk reduction ST segment elevation surgical risk symposium thrombocyte function thrombocytopenia thromboembolism thrombosis thrombosis prevention valvular heart disease vascular endothelium venous thromboembolism Anticoagulants Congresses as Topic
Idioma
Inglês
Citação
Journal of Thrombosis and Thrombolysis, v. 28, n. 1, p. 106-116, 2009.
